Abstract
Based on the specificity of the Watson-Crick base pairing formation, antisense deoxyoligonucleotides have been used to inhibit the expression of oncogenes in various cancer cells. Activation of an oncogene by means of amplification leads to an increased, detectable amount of the mRNA transcript in the cytoplasm. The aim of this study was to demonstrate that cells which are expressing a particular mRNA transcript do preferentially and specifically retain the antisense probe targeting that mRNA. Using a mouse plasmacytoma cell line (MOPC315) which produces high levels of IgA heavy chain mRNA, a control mouse pre B cell line (70ZJ3B), a human mammary cell line (MCF7) which expresses the erbB2 or neu oncogene, MOPC315 cells as neu-negative controls, and antisense DNA oligonucleotides complementary to the 5′ region of the mRNAs and the sense sequence, we have shown that there is a preferential, specific retention of the IgA andneu antisense sequence in MOPC315 and MCF7 cells, respectively. We have further demonstrated that this retention is time and concentration dependent with a maximum at 24 h. We conclude that cancer cells which express a particular oncogene are suitable targets for radiolabeled antisense deoxyoligonucleotides directed toward the oncogene transcript. This work and recent developments in the antisense field lead to the expectation of a new class of radiopharmaceuticals with unique specificity.
Similar content being viewed by others
References
Weinberg RA. Molecular mechanisms of carcinogenesis.Sci Am 1993; 12: 1–14.
Weinberg RA. Oncogenes and tumor suppressor genes.CA Cancer J Clin 1994; 44: 160–170.
Hélène C Toulmé JJ. Specific regulation of gene expression by sense and antisense nucleic acids.Biochem Biophys Acta 1990;1049:99–125.
van der Krol, AR, Mur L, Delange P, Mol JNM, Stuitje AR. Inhibition of flower pigmentation by antisense CHS genes: promoter and minimal sequence requirements for the antisense effect.Plant Mol Biol 1990; 14: 457–466.
Matsukura M, Shinozuka K, Zong G, Mitsuya H, Reitz M, Cohen JS, Broder S. Phosphorothioate analogs of oligonucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.Proc Natl Acad Sci USA 1987; 83: 7706–7710.
Ratajczak MZ, Kant JA, Luger SM, Hijya N, Zhang J, Zon G, Gewirtz AM. In vivo treatment of human leukemia in a SCID mouse model with c-myb antisense oligonucleotides.Proc Natl Acad Sci USA 1992; 89: 11823–11827.
Hijya N, Zhang J, Ratajczak MZ, DeRiel K, Herlyn M, Gewirtz AM. The biological and therapeutic significance of cnzyb expression in human melanoma.Proc Natl Acad Sci USA 1994;91:4499–4503.
Dewanjee MK, Ghafouripour AK, Kapadvanjwala, Dewanjee S, Serafmi AN, Lopez DM, Sfakianakis GN. Noninvasive imaging of c-myc oncogene messenger RNA with indium- 11-antisense probes in a mammary tumor-bearing mouse model.J Nucl Med 1994; 35: 1054–1063.
Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents. Is the bullet really magical?Science 1993; 261: 1004–1012.
Piwnica-Worms D. Making sense out of anti-sense: challenges of imaging gene translation with radiolabeled oligonucleotides.J Nucl Med 1994; 35:1064–1066.
Sakano H, Maki R, Kurosawa Y, Roeder W Tonegawa S. Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes.Nature 1980;286:676–683.
Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.EMBO J 1987; 6: 605–610.
Belikova AM, Zarytova VF, Grineva NI. Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues.Tetrahedron Lett 1967;37:3557–3562.
Urbain JL, Shore S, Vekemans MC, Manzone T, Shea F, Charkes ND, Reddy EP, Malmud LS. Does scintigraphic imaging of antisense probe make sense? Eur J Nucl Med 1994, 10: A207.
Lu X-M L, Fishman AJ, Jyawook SL, Hendricks K, Tompkins RG, Yarmush ML. Antisense DNA delivery in vivo: liver targeting by receptor-mediated uptake. J Nucl Med 1994; 35: 269–275.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Urbain, J.L.C., Shore, S.K., Vekemans, M.C. et al. Scintigraphic imaging of oncogenes with antisense probes: does it make sense?. Eur J Nucl Med 22, 499–504 (1995). https://doi.org/10.1007/BF00817271
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00817271